ArticleScientific reports2025
Formulation optimization of furosemide floating-bioadhesive matrix tablets using waste-derived Citrus aurantifolia peel pectin as a polymer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Natural polymers such as pectin have garnered significant interest in recent years due to their potential applications in gastroretentive drug delivery systems. Gastroretentive dosage forms are intended to extend the emptying time of drugs in the gastrointestinal tract. Accordingly, this study was aimed to examine the use of pectin as a floating and mucoadhesive polymer using furosemide as a model drug. The citrus peel pectin was extracted from local Citrus aurantifolia tree fruit peel using hot water extraction technique. FTIR and DSC analyses were performed to investigate the compatibility of the pectin extracted with furosemide. C. aurantifolia peel yielded 34.4% (w/w) purified pectin with a degree of esterification of 85.49%. FTIR and DSC analysis revealed that the citrus peel pectin powder is compatible with furosemide. Based on preliminary study, pectin and effervescent agent concentration were identified as significant independent variables. Hence, their influence on five response variables (floating duration, bioadhesive strength, swelling index, drug release at 1 h, and drug release rate) were further studied and optimized using central composite design (CCD). Accordingly, the CCD model predicted an optimum formulation at 22.3% of pectin concentration and 5% of effervescent agent. Under this condition, the Design-Expert software predicted floating duration (14.07 s), bioadhesive strength (28.57 g), swelling index (254.08%), drug release at 1 h (27.86%), and drug release rate (28.045%/h
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.